From osimertinib to preemptive combinations Research Perspective
Keywords: lung cancer, NSCLC, EGFR, resistance, afatinib, gefitinib, capmatinib
Search Oncotarget
3,005 results found
— showing 21–40
Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management Research Paper
Keywords: tumor marker, biomarker, lung cancer, NSCLC, translational research
Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas Research Paper
Keywords: sacituzumab govitecan, Trop-2, SN-38, carboplatin, cisplatin
Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper
Keywords: EGFR mutation, leptomeningeal disease, non-small cell lung cancer, osimertinib
Addendum: Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver Addendum
Addendum: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) Addendum
Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Addendum
Transformation of immunosuppressive mtKRAS tumors into immunostimulatory tumors by Nerofe and Doxorubicin Research Paper
Keywords: Colorectal cancer, KRAS, apoptosis, hormone peptide, endoplasmic reticulum stress
Retraction: Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX Retraction
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment Research Paper
Keywords: MALAT1, MAPK-pathway, BRAF, melanoma, antisense oligonucleotides
Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) Research Paper
Keywords: chemotherapy, immunotherapy, non-small cell lung cancer
Obesity paradox and lung cancer, metformin-based therapeutic opportunity? Editorial
Keywords: metformin, tyrosine-kinase inhibitors, BMI, EGFR, obesity paradox
Using cancer proteomics data to identify gene candidates for therapeutic targeting Research Perspective
Keywords: proteomics, proteogenomics, multi-omics, cancer, TTK protein kinase
Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer Editorial
Keywords: non small cell lung cancer, MET mutation, targeted therapy, precision medicine
Cancer prevention with rapamycin Research Perspective
Keywords: chemoprevention, lung, rapamycin, aging, cancer
Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma Retraction
Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma Correction
Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines Research Paper
Keywords: PCAIs, G-proteins, KRAS, RHOA, RAC1
Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior Research Paper
Keywords: Glypican-1, TCGA, bladder carcinoma, hepatocellular carcinoma, glioma
PRRX1 induces epithelial-mesenchymal transition in oesophageal cancer Research Paper
Keywords: PRRX1, oesophageal cancer, epithelial–mesenchymal transition, cancer metastasis